Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D M Jones

Showing results (371-380 of 441) with videos related to

Pageof 45
Sort By:
The Journal of Experimental Medicine|March 1, 1993
Conversion of an immunogenic human immunodeficiency virus (HIV) envelope synthetic peptide to a tolerogen in chimpanzees by the fusogenic domain of HIV gp41 envelope proteinB F Haynes, L O Arthur, P Frost, et al.
Journal of Affective Disorders|July 19, 2023
Treatment outcomes in major depressive disorder in patients with comorbid alcohol use disorder: A STAR*D analysisVictor M Tang, Dengdeng Yu, Cory R Weissman, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 1, 1993
Induction of HIVMN neutralizing antibodies in primates using a prime-boost regimen of hybrid synthetic gp120 envelope peptidesB F Haynes, J V Torres, A J Langlois, et al.
The American Journal of Gastroenterology|August 1, 1990
A prospective study of the prevalence of colonic neoplasms in asymptomatic patients with an age-related riskD A Johnson, M S Gurney, R J Volpe, et al.
Transactions of the Association of American Physicians|January 1, 1993
Use of synthetic peptides in primates to induce high-titered neutralizing antibodies and MHC class I-restricted cytotoxic T cells against acquired immunodeficiency syndrome retroviruses: an HLA-based vaccine strategyB F Haynes, Y Yasutomi, J V Torres, et al.
Bjpsych Open|July 25, 2023
Psilocybin for treatment-resistant depression without psychedelic effects: study protocol for a 4-week, double-blind, proof-of-concept randomised controlled trialMuhammad Ishrat Husain, Daniel M Blumberger, David J Castle, et al.
CNS Spectrums|May 9, 2023
Associations between peripheral inflammation and clinical phenotypes of bipolar depression in a lower-middle income countryBrett D M Jones, Urbee Mahmood, John Hodsoll, et al.
The Journal of Clinical Psychiatry|January 20, 2025
Inpatient Treatment of Suicidality: A Systematic Review of Clinical TrialsAli Abdolizadeh, Brett D M Jones, Maryam Hosseini Kupaei, et al.
Psychological Medicine|December 4, 2022
A cross-sectional study of cognitive performance in bipolar disorder across the lifespan: the cog-BD projectBrett D M Jones, Brisa S Fernandes, M Ishrat Husain, et al.
Global Mental Health (Cambridge, England)|May 28, 2026
Lived experiences of bipolar disorder and family caregiving in PakistanMadeha Umer, Muqaddas Asif, Ameer Bukhsh Khoso, et al.
Pageof 45

Showing results (371-380 of 441) with videos related to

Sort By:
Pageof 45
The Journal of Experimental Medicine|March 1, 1993
Conversion of an immunogenic human immunodeficiency virus (HIV) envelope synthetic peptide to a tolerogen in chimpanzees by the fusogenic domain of HIV gp41 envelope proteinB F Haynes, L O Arthur, P Frost, et al.
Journal of Affective Disorders|July 19, 2023
Treatment outcomes in major depressive disorder in patients with comorbid alcohol use disorder: A STAR*D analysisVictor M Tang, Dengdeng Yu, Cory R Weissman, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 1, 1993
Induction of HIVMN neutralizing antibodies in primates using a prime-boost regimen of hybrid synthetic gp120 envelope peptidesB F Haynes, J V Torres, A J Langlois, et al.
The American Journal of Gastroenterology|August 1, 1990
A prospective study of the prevalence of colonic neoplasms in asymptomatic patients with an age-related riskD A Johnson, M S Gurney, R J Volpe, et al.
Transactions of the Association of American Physicians|January 1, 1993
Use of synthetic peptides in primates to induce high-titered neutralizing antibodies and MHC class I-restricted cytotoxic T cells against acquired immunodeficiency syndrome retroviruses: an HLA-based vaccine strategyB F Haynes, Y Yasutomi, J V Torres, et al.
Bjpsych Open|July 25, 2023
Psilocybin for treatment-resistant depression without psychedelic effects: study protocol for a 4-week, double-blind, proof-of-concept randomised controlled trialMuhammad Ishrat Husain, Daniel M Blumberger, David J Castle, et al.
CNS Spectrums|May 9, 2023
Associations between peripheral inflammation and clinical phenotypes of bipolar depression in a lower-middle income countryBrett D M Jones, Urbee Mahmood, John Hodsoll, et al.
The Journal of Clinical Psychiatry|January 20, 2025
Inpatient Treatment of Suicidality: A Systematic Review of Clinical TrialsAli Abdolizadeh, Brett D M Jones, Maryam Hosseini Kupaei, et al.
Psychological Medicine|December 4, 2022
A cross-sectional study of cognitive performance in bipolar disorder across the lifespan: the cog-BD projectBrett D M Jones, Brisa S Fernandes, M Ishrat Husain, et al.
Global Mental Health (Cambridge, England)|May 28, 2026
Lived experiences of bipolar disorder and family caregiving in PakistanMadeha Umer, Muqaddas Asif, Ameer Bukhsh Khoso, et al.
Pageof 45